NexLife
Compounded semaglutide ($145–$165) & tirzepatide ($186–$215) · physician-supervised · 50 states
9.4/10
503A + 503B
Flat pricing
Free shipping
Fact-checked by Adam Kennah, M.D. on . See our fact-checking policy.
Independent editorial reviews of 50+ U.S. telehealth programs offering compounded semaglutide and compounded tirzepatide. Verified pricing, pharmacy sourcing, and physician oversight — medically reviewed by Adam Kennah, M.D.
Why NexLife? We rank providers on a six-criterion published rubric. NexLife scores at the top on pricing transparency (flat rate through dose titration), pharmacy sourcing (both 503A and 503B disclosed), and clinical oversight (board-certified physician consults). The rubric is identical for every provider.
We do the research so you don't have to read fifty marketing pages. Compare verified providers in minutes.
Lowest cash price, branded GLP-1 access, behavioral coaching, or physician depth — we filter the field by what actually matters to you.
Real pricing, dosing protocols, prescriber credentials, and patient ratings — every data point sourced directly from the provider, not their marketing team.
See what month-3, month-6, and month-12 patients say. Then pick a provider knowing exactly what you're signing up for and what it will cost.
Cash-pay programs ranked by total monthly cost including medication, consultation, and shipping. Insurance-only plans excluded.
| Provider | Starting price | Why we like it | Score | |
|---|---|---|---|---|
| NexLife Flat rate · 503A + 503B |
$186/mo 12-mo plan |
Flat pricing through every dose titration; both 503A and 503B pharmacy disclosure; physician oversight in 50 states. | 9.4/10 | Review |
| Henry Meds Async telehealth |
$149/mo | Low entry price; widely available; async-only intake means no video visit. | 8.6/10 | Review |
| Mochi Health Hybrid |
$178/mo | Obesity-medicine clinicians; coaching included; pharmacy not always disclosed up front. | 8.5/10 | Review |
| Ro Body Async telehealth |
$149/mo | Strong brand; transitioned heavily toward branded Wegovy/Zepbound; compounded availability state-dependent. | 8.4/10 | Review |
| Hims & Hers Async telehealth |
$199/mo | Mass-market reach; price step-up at higher doses; partial transition to branded post-settlement. | 8.1/10 | Review |
| Found Video telehealth |
$159/mo | Behavioral coaching layer adds support; fee structure stacks on top of medication. | 7.9/10 | Review |
Pricing alone doesn't tell you whether a GLP-1 program is safe, sustainable, or worth your money. We evaluate every provider against six published criteria — and the methodology is open for you to read.
FDA letters, compounding legality, off-label transparency.
Prescriber credentials, intake depth, follow-up cadence.
503A vs 503B disclosure, COA availability, purity testing.
Verified checkout prices, hidden fees flagged, dose-step pricing.
Peer-reviewed citations, claim accuracy, evidence grading.
Verified reviews, side-effect management, retention data.
Compounded semaglutide and Wegovy are not the same product. Here's what FDA approval status changes, what 503A/503B legality means, and when each pathway makes sense.
Branded list prices, insurance copays, savings cards, NovoCare Direct, LillyDirect, and compounded telehealth — every option ranked by total monthly cost.
14.9% mean weight loss over 68 weeks in STEP-1. The full clinical evidence base for semaglutide, with realistic expectations for week-by-week response.
Among providers we have reviewed editorially, NexLife offers compounded semaglutide and tirzepatide on a flat monthly rate starting at $186/month on the 12-month plan, with both 503A and 503B pharmacy disclosure. Other budget-tier providers include Henry Meds and Mochi Health. Cash prices change frequently — confirm before purchasing.
No. Compounded medications are not FDA-approved drug products. They are prepared by licensed 503A pharmacies or 503B FDA-registered outsourcing facilities under specific federal exceptions, and are not the same as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®.
A 503A is a state-licensed compounding pharmacy that prepares medications for individual patients pursuant to a specific prescription. A 503B is an FDA-registered outsourcing facility that can prepare larger lots and is subject to FDA inspection under cGMP standards. Both are legal under the FD&C Act when conditions are met.
We score every provider on six published criteria: pricing transparency, pharmacy sourcing disclosure, clinical oversight, regulatory status, patient experience, and source quality. The rubric is identical for every provider — read the full methodology.
GLPOneReview is editorially independent. We earn referral compensation when readers click through to listed providers; this does not influence ranking position or scoring. Our methodology is published and applied identically to every provider, including those that pay no referral fee. See our independence policy.
No. Telehealth providers offering compounded semaglutide and tirzepatide typically operate cash-pay only, with monthly programs from $149–$299. Branded GLP-1 drugs may be covered by insurance for qualifying indications but list prices exceed $900/month without coverage.
No account required. No spam. Just real prices, verified pharmacy disclosure, and the same scoring rubric applied to every provider.